May 16 Deadline Alert: Tostrud Law Group, P.C. Reminds Investors of Upcoming Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc.

LOS ANGELES--()--Tostrud Law Group, P.C. reminds investors of the May 16, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who acquired Insys Therapeutics, Inc. (“Insys” or the “Company”) (NASDAQ: INSY) securities between February 23, 2016 and March 15, 2017, inclusive (the “Class Period”). Insys investors have until May 16, 2017 to file a lead plaintiff motion. Injured investors are encouraged to contact Jon Tostrud, Esq. to discuss their legal rights.

On March 15, 2017, Insys disclosed that it would delay the release of its financial results for the fourth quarter and full year 2016 in order to complete an independent review of the Company’s processes related to sales allowances and extended payment terms. The company further disclosed that the review could result in a reduction of 2015 net revenue and pre-tax income. On this news, shares of Insys fell nearly 5% during trading on March 16, 2017 to close at $10.06 per share, thereby injuring investors.

The Complaint filed in this class action lawsuit alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Insys had overstated its 2015 net revenue; (ii) Insys had misstated its sales allowances for 2016; (iii) accordingly, the Company lacked effective internal controls over financial reporting; and (iv) as a result of the foregoing, Insys’ public statements were materially false and misleading at all relevant times.

Insys investors have until May 16, 2017 to move the Court to appoint you as lead plaintiff in this class action if you meet certain legal requirements. If you have information or would like to learn more about these class action claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to this class action lawsuit, please contact Jon Tostrud, Esquire, of Tostrud Law Group, P.C., 1925 Century Park East, Suite 2100, Los Angeles, California 90067, at (310) 278-2600 or by e-mail at jtostrud@tostrudlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Tostrud Law Group, P.C.
Jon Tostrud, Esq.
(310) 278-2600
jtostrud@tostrudlaw.com
www.tostrudlaw.com

Release Summary

May 16 Deadline Alert: Tostrud Law Group, P.C. Reminds Investors of Upcoming Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc.

Contacts

Tostrud Law Group, P.C.
Jon Tostrud, Esq.
(310) 278-2600
jtostrud@tostrudlaw.com
www.tostrudlaw.com